Early trials of a potential cancer treatment in which white blood cells are modified to target certain types of the disease have been an "extraordinary" success, scientists said Monday.
Early trials of a potential cancer treatment in which white blood cells are modified to target certain types of the disease have been an "extraordinary" success, scientists said Monday.
Please to comment